Aytu Biopharma AYTU
NASDAQ AYTU
$2.07 -0.02 (-0.96%)
At close: Oct 2, 2026 · 4:00 PM EDT

Aytu Biopharma (AYTU) Asset Writedowns and Impairment (2020 - 2026)

Updated

Aytu Biopharma (AYTU) reported Asset Writedowns and Impairment of $400,000 for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 95.0% from $8.06 million a year earlier and down 42.9% from the prior quarter.

Analysis

Aytu Biopharma (AYTU) Asset Writedowns and Impairment (2020 - 2026) Analysis & Trends

For FY2026 (ended Jun 30, 2026), Aytu Biopharma posted Asset Writedowns and Impairment of $2.2 million, down 73.4% from FY2025.

  • Asset Writedowns and Impairment has a five-year compound annual growth rate of -29.7% (FY2021 to FY2026).
  • By fiscal year, Asset Writedowns and Impairment came in at $8.26 million in FY2025 (+588.6%), $1.2 million in FY2024 (-79.0%), $5.71 million in FY2023 (-92.4%) and $75.46 million in FY2022 (+488.4%).
  • Five-year quarterly Asset Writedowns and Impairment spans a low of $100,000 in fiscal Q2 2022 and a high of $45.2 million in fiscal Q3 2022.
  • Year over year, Asset Writedowns and Impairment gained in four of the last eight quarters, with growth averaging 256.9%.
  • The high point for year-over-year Asset Writedowns and Impairment in five years was fiscal Q2 2026 (growth of 700.0%); the low point was fiscal Q3 2023 (a decline of 99.8%).
  • Per Business Quant data, the three fiscal quarters before Q4 2026 came in at $700,000 (Q3 2026), $800,000 (Q2 2026) and $300,000 (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Aytu Biopharma 22.49 Mn -93.18 Mn 10.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 400,000.00
Mar 31, 2026 700,000.00
Dec 31, 2025 800,000.00
Sep 30, 2025 300,000.00
Jun 30, 2025 8.06 Mn
Mar 31, 2025 100,000.00
Dec 31, 2024 100,000.00
Sep 30, 2024 100,000.00
Jun 30, 2024 1.08 Mn
Mar 31, 2024 100,000.00
Dec 31, 2023 100,000.00
Sep 30, 2023 100,000.00
Jun 30, 2023 3.11 Mn
Mar 31, 2023 100,000.00
Dec 31, 2022 2.60 Mn
Sep 30, 2022 100,000.00
Jun 30, 2022 10.81 Mn
Mar 31, 2022 45.20 Mn
Dec 31, 2021 100,000.00
Sep 30, 2021 19.45 Mn
API Access

Aytu Biopharma Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=AYTU&period=max&api_key=YOUR_API_KEY